Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersHematology & Oncology Physician in Washington, DC
NPI: 1275723199Primary Practice Location
MEDSTAR WASHINGTON HOSPITAL CENTER
110 Irving St Nw, Washington, DC
Primary Employer
Medstar Medical Group II LLC
medstarhealth.org
HQ Phone
Get M.D. Suthee's Phone Numberphone_androidMobile
Get M.D. Suthee's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardDC State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99215Established patient office or other outpatient, visit typically 40 minutes | 144 | 422 |
| 2 | 99205New patient office or other outpatient visit, typically 60 minutes | 58 | 58 |
| 3 | G2212Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 56 | 67 |
| 4 | 99214Established patient office or other outpatient visit, 30-39 minutes | 38 | 63 |
| 5 | 99223Initial hospital inpatient care, typically 70 minutes per day | 29 | 29 |
Dissecting the treatment-naive ecosystem of human melanoma brain metastasis.
Authors: Jeffrey Bruce, Richard Carvajal, Craig Slingluff, Markus Siegelin, Sana Habib, Antoni Ribas, Michael Davies, Shaheer Khan, Blake Caldwell, Benjamin Izar, Peter Canoll, Matthew Ingham
Journal: Cell
Authors: Eric Miller, Mehmet Bilen, Matthew Galsky, Benjamin Maughan, Bradley Carthon
Journal: Cancer
Publication Date: 2024-01-05
Authors: Janice Mehnert, Maya Dimitrova
Journal: JAMA Oncol
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: PROCEDURE: Magnetic Resonance Imaging, PROCEDURE: Biospecimen Collection, DRUG: Cisplatin, PROCEDURE: Therapeutic Conventional Surgery, DRUG: Gemcitabine Hydrochloride, BIOLOGICAL: Pegfilgrastim, DRUG: Methotrexate, PROCEDURE: Computed Tomography, BIOLOGICAL: Durvalumab, PROCEDURE: Biopsy Procedure, DRUG: Vinblastine Sulfate, DRUG: Doxorubicin Hydrochloride
Lead Sponsor: Georgetown University
Collaborators: Bristol-Myers Squibb, University of California, San Francisco, Vanderbilt University, Yale University, Northwestern University, Columbia University, University of Pittsburgh, University of Colorado, Denver, M.D. Anderson Cancer Center, Dana-Farber Cancer Institute, H. Lee Moffitt Cancer Center and Research Institute, Memorial Sloan Kettering Cancer Center, Melanoma Research Foundation Breakthrough Consortium
Intervention / Treatment: DRUG: Ipilimumab, DRUG: Nivolumab
Lead Sponsor: Suthee Rapisuwon
Collaborators: Bristol-Myers Squibb
Intervention / Treatment: DRUG: Ipilimumab, DRUG: Nivolumab
